Community Search
Come Meet Us: Latest News

FDA Sets Priority Review for PD Psychosis Drug

Wednesday, November 4, 2015   (0 Comments)
Share |

ACADIA Pharmaceuticals Announces FDA Priority Review of NUPLAZID™ (Pimavanserin) New Drug Application for Parkinson’s Disease Psychosis

 

Click here to read more: http://www.businesswire.com/news/home/20151102005516/en/ACADIA-Pharmaceuticals-Announces-FDA-Priority-Review-NUPLAZID™


Membership Management Software Powered by YourMembership  ::  Legal